Literature DB >> 266314

Acute nonlymphoblastic leukemia in adults. Where do we go from here.

J R Bert.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 266314      PMCID： PMC1237559     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  6 in total

1.  Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).

Authors:  J Manaster; D H Cowan; J E Curtis; R Hasselback; D E Bergsagel
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

2.  Immunotherapy in the management of acute leukaemia.

Authors:  R L Powles
Journal:  Br J Haematol       Date:  1976-02       Impact factor: 6.998

3.  Current concepts in the treatment of adult leukemia.

Authors:  J R Bertino; R T Skeel
Journal:  Conn Med       Date:  1974-10

4.  Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.

Authors:  J P Whitecar; G P Bodey; E J Freireich; K B McCredie; J S Hart
Journal:  Cancer Chemother Rep       Date:  1972-08

5.  Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).

Authors:  J O Armitage; C P Burns
Journal:  Cancer Treat Rep       Date:  1976-05

6.  Treatment of acute leukemia in adults.

Authors:  B D Clarkson; M D Dowling; T S Gee; I B Cunningham; J H Burchenal
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.